Annual Meeting Press Advisory
The Liver Meeting® is the premier meeting in the science and practice of hepatology, including the latest findings on new drugs, novel treatments, and the results from pilot and multicenter studies.
Approximately 10 percent of Americans have some form of liver disease, and the diseases strike disproportionately among certain populations but mostly regardless of lifestyle choices. There are now numerous treatments for both hepatitis B and C, and screening, treatment, and prevention of hepatitis remain important issues. Liver cancer is one of the few cancers growing in incidence, and the obesity epidemic has dire consequences for the nation’s liver health and wellness.
The almost 2000 abstracts addressing these issues that will be presented are available to members of the press at our website (www.aasld.org), including almost 240 abstracts that will be presented in oral sessions.
Boston, MA – October 31 - November 3, 2009
• Poster Presentations: October 31 – November 3
• Oral Presentations: November 1 – 3
An AASLD President’s press conference highlighting key abstracts and issues presented at the Liver Meeting® is scheduled for Saturday, October 31 at 4:00 pm. 
Click here for a complete list of highlighted abstracts.
Founded in 1950, AASLD is the leading organization of scientists and healthcare professionals committed to preventing and curing liver disease. AASLD has grown into an international society responsible for all aspects of hepatology, and our annual meeting attracts 7,500 physicians, surgeons, researchers, and allied health professionals from around the world.
Please contact AASLD at 703-299-9766 for information about the above presentations, or to receive any additional information about The Liver Meeting® – or visit our website at www.aasld.org.
Gregory Bologna gbologna@aasld.org
Ann Tracy atracy@aasld.org
Please contact Ann Tracy to register as press for the meeting: 703-299-9766 or atracy@aasld.org
Press Releases
Vitamin supplements insufficient for children with biliary atresia
Difficult-to-treat patient populations respond positively to hepatitis C treatment
Women are at greater risk than men of graft loss after undergoing liver transplantation for Hepatitis C-related liver disease
New epidemic of sexually transmitted hepatitis C infection in HIV-infected men in NYC
Vitamin E improves NASH
African Americans fare worse after undergoing liver transplantation due to hepatitis C
Noninvasive Breath Test Predicts Survival in Patients with Viral Hepatitis
Twice daily oral medication shows promise in treating patients with hepatitis C
Embargo Policy
Accepted abstracts are made available to the public on the AASLD website on publication of the special supplement of HEPATOLOGY in advance of the meeting. Information contained in those abstracts may not be released until the abstracts appear on the AASLD website.
Academic institutions, private organizations and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of the abstract on the AASLD website. However, AASLD requires information that goes beyond that contained in the abstract, e.g., discussion of the abstract done as part of a scientific presentation or presentation of additional or new information that will be available at the time of the meeting, is under embargo from release to the general public until 5:30pm October 31. Information released prior to this day is a violation of the AASLD Abstract Embargo Policy and the abstract is subject to withdrawal from The Liver Meeting® program. Authors are responsible for notifying financial and other sponsors about this policy.
Accreditation
If you are a freelance journalist, a statement from the Managing Editor or equivalent of a trade publication, mainstream media outlet (newspaper, radio, television, etc.), or an online magazine stating that you will be covering the event on behalf of that particular media outlet.
In lieu of such statement, please send us a published story you have written on a scientific, technical, or medical subject. If you are employed full time on an editorial staff, please fax or email us the masthead of the publication